Review Article
Postnatal Corticosteroids for Prevention and Treatment of Chronic Lung Disease in the Preterm Newborn
Table 3
RCTs of early hydrocortisone to prevent BPD.
| Study, no. of centers | n | Population: mechanically ventilated infants | Timing | Hydrocortisone dosing regimen | Rate of survival without BPD HC versus placebo, % |
| Watterberg et al. [49], 2 centers | 40 | BW: 500–999 g | <48 h postnatal age | 0.5 mg/kg every 12 h for 9 days 0.25 mg/kg every 12 h for 3 days | 60 versus 35 () | Watterberg et al. [50], 9 centers | 360 | BW: 500–999 g | <48 h postnatal age | 0.5 mg/kg every 12 h for 12 days 0.25 mg/kg every 12 h for 3 days | 35 versus 34 (OR: 1.20 (95% CI: 0.72–1.99)) | Peltoniemi et al. [51], 3 centers | 51 | BW: 501–1250 g | <36 h postnatal age | 2.0 mg/kg/day tapered to0.75 mg/kg/day over 10 days | 64 versus 46 (OR: 1.48 (95% CI: 0.49–4.48)) | Bonsante et al. [52], 2 centers | 50 | BW: 500–1249 g | <48 h postnatal age | 0.5 mg/kg every 12 h for 9 days; 0.25 mg/kg every 12 h for 3 days | 64 versus 32 () |
|
|